OTTAWA, ON – Innovative Medicines Canada (IMC) is pleased to announce that Cole C. Pinnow, President, Pfizer Canada ULC, has been elected Chair of its Board of Directors. “Cole worked… Read More
We warmly invite you to join a virtual open house at our sites in Vancouver (Canada) and Birmingham (USA) on Wednesday, December 15, 2021. Even in times of COVID-19, we… Read More
OTTAWA, ON – Innovative Medicines Canada (IMC) and Hoffmann-La Roche Limited (Roche Canada) today announced a $50,000 Scholarship in Artificial Intelligence and Population Health for the Dalla Lana School of Public… Read More
On December 1st, Silicon Valley Bank and #GrowTogether will be bringing together a powerhouse panel of Founders, Funders and Influencers to present a bespoke Fundraising Bootcamp, a ‘crash course’ designed to… Read More
Phase III POLARIX trial showed Polivy plus R-CHP was the first treatment in two decades to significantly improve outcomes in newly diagnosed diffuse large B-cell lymphoma (DLBCL) versus the standard of care1… Read More
